GlassScriptPhysician profile
Gerard D Brocato
NPI 1649377664
$4,521.68
in general payments reported to CMS, 2019-2025
13 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $53.58 · 2021: $636 · 2022: $1,557 · 2023: $334 · 2024: $670 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.61 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,164.61 | 2019-2025 | Scopis Ent, Xpress Loprofile, Xpress Ent Dilation System |
| Optinose US, INC. | $326.49 | 2019-2024 | |
| Glaxosmithkline, LLC. | $303.29 | 2022-2024 | Nucala |
| Genzyme Corporation | $271.67 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $103.09 | 2021-2024 | Dupixent |
| Kerecis Limited | $102.78 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Smith+Nephew, INC. | $47.82 | 2025 | Oasis, Stravix Mesh |
| Kowa Pharmaceuticals America, INC. | $29.97 | 2023 | Seglentis |
| Abiomed | $28.06 | 2025 | |
| Merck Sharp & Dohme LLC | $19.47 | 2021 | |
| Aerin Medical INC. | $12.69 | 2023 | |
| Hologic Sales and Service, LLC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Brocato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.